Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-alpha or interleukin-6
- PMID: 1516039
- DOI: 10.1016/0304-3835(92)90238-q
Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-alpha or interleukin-6
Abstract
Daily administration of an escalating dose of tumour necrosis factor-alpha (TNF-alpha) to female NMRI mice caused a progressive loss of body weight representing 12% of the original weight over a 6-day period. Weight loss was associated with a decreased food intake and pair-fed controls exhibited a weight loss of similar magnitude to that caused by TNF-alpha. However, weight loss in animals bearing a murine adenocarcinoma (MAC16) occurred without a change in energy intake and thus differed from that produced by TNF-alpha. Anti-TNF-alpha monoclonal antibodies at levels capable of protecting mice against lethal endotoxaemia were ineffective in reversing weight loss in animals bearing the MAC16 tumour and had no effect on the increase in tumour volume. Circulating levels of interleukin-6 were not elevated in animals bearing the MAC16 tumour and with a weight loss between 1.8 and 5.4 g. These results suggest that these cytokines are not involved in the cachexia produced by this murine tumour.
Similar articles
-
Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.Br J Cancer. 1988 Apr;57(4):385-9. doi: 10.1038/bjc.1988.87. Br J Cancer. 1988. PMID: 3390373 Free PMC article.
-
Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.Br J Cancer. 1990 Sep;62(3):420-4. doi: 10.1038/bjc.1990.310. Br J Cancer. 1990. PMID: 2206950 Free PMC article.
-
Role of NF-kappaB and cytokine in experimental cancer cachexia.World J Gastroenterol. 2003 Jul;9(7):1567-70. doi: 10.3748/wjg.v9.i7.1567. World J Gastroenterol. 2003. PMID: 12854165 Free PMC article.
-
Pathophysiology of cancer cachexia.Support Care Cancer. 1993 Nov;1(6):290-4. doi: 10.1007/BF00364965. Support Care Cancer. 1993. PMID: 8156245 Review.
-
Cytokines and cachexia.Nutrition. 1997 Sep;13(9):763-70. doi: 10.1016/s0899-9007(97)00185-8. Nutrition. 1997. PMID: 9290087 Review.
Cited by
-
Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.Br J Cancer. 2000 Jul;83(1):56-62. doi: 10.1054/bjoc.2000.1278. Br J Cancer. 2000. PMID: 10883668 Free PMC article.
-
Are cytokines possible mediators of cancer cachexia?Surg Today. 1996;26(7):467-75. doi: 10.1007/BF00311551. Surg Today. 1996. PMID: 8840426 Review.
-
Mechanism of muscle protein degradation induced by a cancer cachectic factor.Br J Cancer. 1998 Oct;78(7):850-6. doi: 10.1038/bjc.1998.592. Br J Cancer. 1998. PMID: 9764574 Free PMC article.
-
Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.Br J Cancer. 2005 Aug 22;93(4):425-34. doi: 10.1038/sj.bjc.6602725. Br J Cancer. 2005. PMID: 16052213 Free PMC article.
-
The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia.Br J Cancer. 2005 Mar 14;92(5):876-81. doi: 10.1038/sj.bjc.6602404. Br J Cancer. 2005. PMID: 15714206 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources